Tazicef Injection, Powder, For Solution
Product Images NDC 0409-5086

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Tazicef (NDC 0409-5086). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hospira, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Hospira Logo (Tazicef 01)

Hospira Logo (Tazicef 01)
This appears to be a partial text and does not provide enough context to generate a useful description.*
FDA Label Image

Structural Formula Ceftazidime (Tazicef 02)

FDA Label Image

Hospira Logo (Tazicef 03)

FDA Label Image

Principal Display Panel (6 gram Vial Label)

Principal Display Panel (6 gram Vial Label)
This is a description of an Injection, USP of Cefazolin. The text provides information regarding the dosage, administration, and storage of the medication. The drug is available in a bulk vial for institutional and intravenous use, and it should not be used for direct infusion. The vial is under reduced pressure, and the addition of the diluent generates positive pressure. Before reconstitution, the vial needs to be stored at a controlled room temperature. The usual adult dose is 1 gram every 8 to 12 hours, and 2 grams every 8 hours in severe cases. The reconstituted solution is stable for 24 hours at room temperature or 5 days if refrigerated. This injectable drug is manufactured by Sandoz GmbH for Hospira, Inc.*
FDA Label Image

Principal Display Panel (6 gram Vial Tray Label)

Principal Display Panel (6 gram Vial Tray Label)
This is a description of Ceftazidime, a drug primarily for institutional use, available in a vial with NDC 0409-5086-11. It is administered using Sodium Chloride Injection, Sterile or Water for Injection, and is stable for 24 hours at room temperature or 7 days in the fridge when properly reconstituted. The usual adult dosage is 1 gram every 8 to 12 hours, increasing to 2 grams every 8 hours in severe cases. Detailed instructions are provided, including possible side effects and precautions.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.